C

Chemistree Technology Inc
CNSX:CHM

Watchlist Manager
Chemistree Technology Inc
CNSX:CHM
Watchlist
Price: 0.005 CAD Market Closed
Market Cap: 3.7m CAD

Relative Value

There is not enough data to reliably calculate the relative value of CHM.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CHM Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.7
vs History
vs Industry
Median 3Y
-7.4
Median 5Y
-33.4
Industry
21.6
vs History
vs Industry
Median 3Y
-19.2
Median 5Y
-82.7
Industry
16.9
vs History
vs Industry
Median 3Y
-19.2
Median 5Y
-82.7
Industry
22.9
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-5.7
Industry
2.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.6
vs History
vs Industry
Median 3Y
-10.4
Median 5Y
-47.5
Industry
13.4
vs History
vs Industry
Median 3Y
-11.1
Median 5Y
-50.2
Industry
16.7
vs History
vs Industry
Median 3Y
-19.4
Median 5Y
-82.6
Industry
16.1
vs History
vs Industry
Median 3Y
-19.4
Median 5Y
-82.6
Industry
18.9
vs History
79
vs Industry
4
Median 3Y
53.3
Median 5Y
140.7
Industry
2

Multiples Across Competitors

CHM Competitors Multiples
Chemistree Technology Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Chemistree Technology Inc
CNSX:CHM
3.7m CAD 0 -3.7 -5.3 -5.6
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55.1 37 39.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
525.9B USD 5.7 20.9 17.1 22.2
CH
Roche Holding AG
SIX:ROG
275B CHF 4.5 29.2 12.4 14.5
UK
AstraZeneca PLC
LSE:AZN
221.5B GBP 5.1 31.7 109.1 159.7
CH
Novartis AG
SIX:NOVN
223.2B CHF 5 19.4 12.3 15.8
US
Merck & Co Inc
NYSE:MRK
276.1B USD 4.3 14.5 10.3 12.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.2 15.9 11.1 12.9
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
145.4B USD 2.3 14.8 7.5 10.3
P/E Multiple
Earnings Growth PEG
CA
C
Chemistree Technology Inc
CNSX:CHM
Average P/E: 25.2
Negative Multiple: -3.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.1
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.2
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.7
37%
0.9
CH
Novartis AG
SIX:NOVN
19.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
15.9
3%
5.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.8
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
C
Chemistree Technology Inc
CNSX:CHM
Average EV/EBITDA: 440.2
Negative Multiple: -5.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17.1
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.4
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
109.1
10%
10.9
CH
Novartis AG
SIX:NOVN
12.3
6%
2
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11.1
1%
11.1
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
C
Chemistree Technology Inc
CNSX:CHM
Average EV/EBIT: 1 883.9
Negative Multiple: -5.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.6
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.2
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.5
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.7
23%
6.9
CH
Novartis AG
SIX:NOVN
15.8
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.9
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
7%
1.5